Latin American research indicates a lower prevalence of a type of head and neck cancer

Squamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth ...
BioWorld

A three-armed activator of natural killer cells against head and neck squamous cell carcinoma

Prognosis is extremely poor for patients with head and neck squamous cell carcinoma (HNSCC), which accounts for around 90% of all head and neck cancer. Especially in the more aggressive subtype of ...
Nature

Esophageal Cancer in Head and Neck Squamous Cell Carcinoma

Esophageal cancer occurring in patients with head and neck squamous cell carcinoma (HNSCC) represents a critical clinical challenge, as these secondary tumours notably worsen patient prognosis. Owing ...
Healio

Adjuvant nivolumab improves DFS in high-risk head and neck cancer

Please provide your email address to receive an email when new articles are posted on . Patients who received nivolumab had longer DFS than those who received standard care. OS will be evaluated after ...
Medscape

NECTORS for Advanced HPV-Related Head and Neck Cancer?

Compared with standard concurrent chemoradiation, neoadjuvant chemotherapy followed by transoral robotic surgery (NECTORS) and neck dissection led to superior distant metastasis-free and overall ...
Healio

Combination immunotherapy better than single agent in head, neck cancer

Please provide your email address to receive an email when new articles are posted on . Neoadjuvant combination immunotherapy regimens produced higher pathologic response rates than monotherapy in a ...
The Manila Times

Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

(ORR) and 92% disease control rate (DCR) observed with MICVO as monotherapy in 2L+ R/M HNSCC at 5.4 mg/kg 71% confirmed ORR ...